|
Feb 9
|
Ionis' (IONS) Eplontersen Gets Fast Track Tag for New Indication
|
|
Feb 9
|
Pharma Stock Roundup: AZN & LLY's Q4 Earnings, NVO, NVS & MRK's M&A Deals
|
|
Feb 8
|
Energy & Utilities Roundup: Market Talk
|
|
Feb 8
|
AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript
|
|
Feb 8
|
AstraZeneca Nose Dives On 'Thoroughly Underwhelming' Fourth-Quarter Results
|
|
Feb 8
|
Astrazeneca (AZN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
Feb 8
|
Car giant Ford to axe 2,700 German jobs
|
|
Feb 8
|
Health Care Roundup: Market Talk
|
|
Feb 8
|
AstraZeneca Shares Drop on Weak Quarterly Report Despite 2024 Growth Guidance
|
|
Feb 8
|
AstraZeneca Stock Slips on Soft Earnings Report as Cancer Drug Sales Disappoint
|
|
Feb 8
|
Weight loss drugs make patients lose muscle mass, says AstraZeneca chief
|
|
Feb 8
|
AstraZeneca (AZN) Q4 Earnings & Sales Miss Estimates, Stock Down
|
|
Feb 8
|
UPDATE 2-Astrazeneca says Catalent deal shows need for in-house capacity
|
|
Feb 8
|
Astrazeneca says Catalent deal shows need for in-house capacity
|
|
Feb 8
|
UPDATE 2-European shares edge lower as healthcare losses overpower earnings-fuelled rally
|
|
Feb 8
|
UPDATE 2-FTSE 100 retreats as AstraZeneca earnings disappoint
|
|
Feb 8
|
London Stocks Edge Up as BAT, Unilever Gain After Earnings Updates; AstraZeneca Falls
|
|
Jan 27
|
3 Magnificent Stocks to Buy and Hold Forever
|
|
Jan 25
|
24 Least Developed Countries in Europe in 2024
|
|
Jan 25
|
PRESS DIGEST-British Business - Jan 25
|